Everest Medicines Limited
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline produc…
Biotechnology
CN, Shanghai [HQ]
Balance Sheet
6 Sheets · From 2023 to 2018Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Assets | 723.00 | 2,136.00 | 7,477.00 | 6,645.00 | 6,614.00 | 5,772.00 | |
|
Current
|
209.00 | 131.00 | 4,496.00 | 2,687.00 | 3,414.00 | 2,507.00 | |
| Cash And Equivalents | 183.00 | 106.00 | 4,481.00 | 2,640.00 | 490.00 | 523.00 | |
| Assets | 723.00 | 2,136.00 | 7,477.00 | 6,645.00 | 6,614.00 | 5,772.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | -5.00 | -44.00 | |
| Inventory | - - | - - | - - | - - | 11.00 | 18.00 | |
| Short Term Investments | - - | - - | 2.00 | - - | 1,160.00 | 1,826.00 | |
| Other Current Assets | - - | - - | - - | - - | - - | - - | |
|
Non Current
|
513.00 | 2,005.00 | 2,980.00 | 3,957.00 | 3,200.00 | 3,265.00 | |
| Property, Plant, Equipment (Net) | 18.00 | 46.00 | 86.00 | 253.00 | 690.00 | 651.00 | |
|
Intangible Assets
|
493.00 | 1,663.00 | 2,041.00 | 2,850.00 | 2,412.00 | 2,556.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | 34.00 | 845.00 | 830.00 | -1,071.00 | 48.00 | |
| Other Non Current Assets | 1.00 | 296.00 | 852.00 | 853.00 | 97.00 | 8.00 | |
| Liabilities | 1,670.00 | 2,998.00 | 636.00 | 753.00 | 960.00 | 804.00 | |
|
Current
|
159.00 | 503.00 | 186.00 | 270.00 | 870.00 | 300.00 | |
| Accounts Payable | - - | - - | - - | - - | 5.00 | - - | |
| Short Term Debt | 5.00 | 10.00 | 19.00 | 28.00 | 444.00 | 41.00 | |
| Deferred Revenue | - - | - - | - - | - - | - - | 27.00 | |
| Tax Payable | - - | 1.00 | 3.00 | 4.00 | 5.00 | 3.00 | |
| Other Current Liabilities | 152.00 | 453.00 | 127.00 | 187.00 | 381.00 | 181.00 | |
|
Non Current
|
1,510.00 | 2,494.00 | 449.00 | 483.00 | 90.00 | 503.00 | |
| Long Term Debt | 10.00 | 30.00 | 428.00 | 456.00 | 59.00 | 469.00 | |
| Leasing Obligations | 16.00 | 40.00 | 77.00 | 124.00 | 79.00 | 58.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | 22.00 | |
| Other Non Current Liabilities | 1,499.00 | 2,463.00 | 20.00 | 26.00 | 30.00 | 6.00 | |
| Equity | -947.00 | -861.00 | 6,841.00 | 5,891.00 | 5,654.00 | 4,968.00 | |
| Stockholders' Equity | -947.00 | -861.00 | 6,841.00 | 5,891.00 | 5,654.00 | 4,968.00 | |
| Retained Earnings | -1,043.00 | -1,257.00 | -6,916.00 | -7,924.00 | -8,172.00 | -9,016.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | |
| Profit | -991.00 | -193.00 | -5,681.00 | -1,013.00 | -247.00 | -844.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 101.00 | - - | - - | -58.00 | - - | - - | |
| Loss Other Compr. Income | -5.00 | 396.00 | 13,756.00 | 13,875.00 | 13,826.00 | 13,984.00 |